NFKB1 and liver dysplastic nodule: The suppression of NF-κB activation by various agents such as thiazolidinediones, 1,25-dihydroxyvitamin D3, cilostazol, oridonin, and curcumin could lead to the improvement of DN, suggesting the significance of NF-κB as a therapeutic target in DN (Kumar et al., 2001; Lee et al., 2004, 2010; Pillarisetti and Saxena, 2004; Ohga et al., 2007; Zhang et al., 2007; Liang et al., 2010; Soetikno et al., 2011; Li et al., 2018).